PRAX
Praxis Precision Medicines, Inc.
NASDAQ · Healthcare · Biotechnology · US
$260.17
+7.61%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$3.54
- Revenue estimate
- $130.8K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$2.87
- EPS estimate
- -$3.67
- Revenue actual
- —
- Revenue estimate
- $1.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +4.6%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $677
- PT range
- $362 – $1.2K
- Analysts
- 8
7 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$3.67 | -$2.87 | Beat 21.80% | — |
| May 7, 2026 | -$3.58 | -$3.20 | Beat 10.61% | — |
| Feb 19, 2026 | -$3.00 | -$3.50 | Miss -16.67% | — |
| Nov 5, 2025 | -$3.45 | -$3.36 | Beat 2.61% | — |
| May 2, 2025 | -$3.20 | -$3.29 | Miss -2.81% | — |
| Feb 28, 2025 | -$2.76 | -$2.94 | Miss -6.52% | $7.5M |
| Aug 13, 2024 | -$2.38 | -$1.74 | Beat 26.89% | $357.0K |
| Mar 5, 2024 | -$3.15 | -$2.97 | Beat 5.71% | $515.0K |
| May 11, 2023 | -$11 | -$11 | Beat 5.34% | $683.0K |
| Feb 7, 2023 | -$11 | -$13 | Miss -19.20% | — |
| Nov 9, 2022 | -$14 | -$14 | Miss -4.35% | — |
| Feb 28, 2022 | -$16 | -$19 | Miss -20.38% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026